QuadVantage Technology

QuadVantage Technology

Early Stage

Transforming ACL Reconstruction Surgery

Transforming ACL Reconstruction Surgery

Overview

Raised this Round: Raised: $295,750

Total Commitments ($USD)

Platform

Dealmaker Securities

Start Date

08/07/2022

Close Date

04/10/2023

Min. Goal
$25,000
Max. Goal
$5,000,000
Min. Investment

$500

Security Type

Equity - Preferred

Series

Seed

SEC Filing Type

RegCF    Open SEC Filing

Price Per Share

$2.50

Pre-Money Valuation

$9,800,000

Year Founded

2018

Industry

Healthcare & Pharmaceuticals

Tech Sector

HealthTech

Distribution Model

B2B

Margin

Low

Capital Intensity

High

Location

Raleigh, North Carolina

Business Type

Growth

QuadVantage Technology is raising funds on Dealmaker Securities. The company is transforming ACL reconstruction surgery with its QuadVantage Autograft System. The QuadVantage Quadriceps Autograft System makes the harvesting of Quadriceps tendon easier, more precise, less painful, and less traumatic. QuadVantage’s technology is clinically tested and has received FDA approvals. The technology helps to eliminate guesswork, leaves only a small scar, and costs less compared to competitors. Thomas Gutierrez founded QuadVantage Technology in October 2018. The current crowdfunding campaign has a minimum target of $25,000 and a maximum target of $5,000,000. The campaign proceeds will be used for growth and expansion.

Summary Profit and Loss Statement

Most Recent Year Prior Year

Revenue

$0

$0

COGS

$0

$0

Tax

$670

$20

 

 

Net Income

$-1,222,273

$-536,739

Summary Balance Sheet

Most Recent Year Prior Year

Cash

$6,943

$3,829

Accounts Receivable

$0

$0

Total Assets

$25,166

$197,555

Short-Term Debt

$1,796,792

$599,901

Long-Term Debt

$204,617

$556,234

Total Liabilities

$2,001,409

$1,156,135

Financials as of: 08/07/2022
Create a free account today to gain access to KingsCrowd analytics.

Upgrade to gain access

Pay Monthly
Annually (Save 17%)

Edge

$25 /month
billed annually
Free portfolio tracking, data-driven ratings, AI analysis and reports
Plan Includes:
Everything in Free, plus
Company specific KingsCrowd ratings and analyst reports
Deal explorer and side-by-side comparison
Startup exit and failure tracking
Startup market filters and historical industry data
Advanced company search ( with ratings)
Get Edge Annual
Already a member? Log in here.

Ratings KingsCrowd Startup Rating Methodology Article

Blurred Ratings Bars Blurred Ratings Bars
Founders: enhance your startup's credibility on KingsCrowd. Create an account to claim this raise page.
Add to portfolio
QuadVantage Technology on Dealmaker Securities 2022
Platform: Dealmaker Securities
Security Type: Equity - Preferred
Valuation: $9,800,000
Price per Share: $2.50

Follow company

Follow QuadVantage Technology on Dealmaker Securities 2022

Buy QuadVantage Technology's Deal Report

Warning: according to the close date for this deal, QuadVantage Technology may no longer be accepting investments.

QuadVantage Technology Deal Report

Get KingsCrowd’s comprehensive report on QuadVantage Technology including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether QuadVantage Technology is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise

Buy the QuadVantage Technology deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge